Novel Concepts in the Genesis of Hypertension: Role of LOX-1

被引:0
|
作者
Ping Luo
Meiling Yan
Edward D. Frohlich
Jawahar L. Mehta
Changping Hu
机构
[1] Central South University,Department of Pharmacology, School of Pharmaceutical Sciences
[2] Ochsner Clinic Foundation,Division of Cardiovascular Medicine
[3] University of Arkansas for Medical Sciences and the Central Arkansas Veterans Healthcare System,undefined
来源
关键词
Hypertension; Lectin-like oxidized low-density lipoprotein receptor-1; Oxidative stress; Angiotensin II;
D O I
暂无
中图分类号
学科分类号
摘要
Hypertension is a common disease and a potent risk factor for cardiovascular disease. Tremendous strides have been made in understanding its genesis in the last 2 decades. Hypertension is often clustered with other cardiovascular risk factors, such as dyslipidemia and diabetes. The state of hypertension is often associated with increased vascular oxidative stress. Oxidative stress promotes proliferation and hypertrophy of vascular smooth muscle cell and collagen deposition, leading to thickening of the vascular media and narrowing of the vascular lumen. Oxidative stress also injures endothelium, impairs endothelium-dependent vascular relaxation and increases vascular contractile activity. Further, oxidative stress also oxidizes LDL-cholesterol. It has been shown that oxidized low-density lipoprotein (ox-LDL) activates renin-angiotensin system (RAS) and angiotensin II via its type 1 receptor activates ox-LDL receptor LOX-1. This mutually facilitative cross-talk between ox-LDL and RAS may be an important component in the development of hypertension. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a receptor for ox-LDL. This review summarizes the role of LOX-1 in the pathogenesis of hypertension.
引用
收藏
页码:441 / 449
页数:8
相关论文
共 50 条
  • [41] Role of Endothelin-1 in Upregulation of LOX-1 Expression in Hypertensive Rats
    Schnell, Michael
    Remmler, Cornelia
    Kunert-Keil, Christiane
    Cascorbi, Ingolf
    Peters, Barbara
    Peters, Joerg
    Kroemer, Heyo K.
    Staudt, Alexander
    Felix, Stephan B.
    Landsberger, Martin
    CIRCULATION, 2008, 118 (18) : S1036 - S1037
  • [42] Nuclear Role of LOX-1 in XinMaiJia-attenuating Atherosclerosis in Rabbits
    Sun, R. L.
    Zhu, T. T.
    Zhu, M. L.
    Song, P.
    Xu, J.
    Yin, Y. L.
    Li, P.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 81 (06) : 1020 - 1028
  • [43] Biology of LOX-1 in relation to atherogenesis
    Hu, Changping
    Mehta, Jawahar L.
    FUTURE LIPIDOLOGY, 2008, 3 (06): : 689 - 696
  • [44] LOX-1 and cancer: an indissoluble liaison
    Murdocca, M.
    De Masi, C.
    Pucci, S.
    Mango, R.
    Novelli, G.
    Di Natale, C.
    Sangiuolo, F.
    CANCER GENE THERAPY, 2021, 28 (10-11) : 1088 - 1098
  • [45] LOX-1 and Angiotensin Receptors, and Their Interplay
    Xianwei Wang
    M. Ian Phillips
    Jawahar L. Mehta
    Cardiovascular Drugs and Therapy, 2011, 25 : 401 - 417
  • [46] Oxidized LDL, LOX-1 and Atherosclerosis
    Mitra, Sona
    Goyal, Tanu
    Mehta, Jawahar L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2011, 25 (05) : 419 - 429
  • [47] LOX-1 AND DIABETIC NEUROPATHY IN MICE
    Vincent, A. M.
    McLean, L. L.
    Feldman, E. L.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S143 - S144
  • [48] LOX-1 and mitochondria: an inflammatory relationship
    Christ, Anette
    Latz, Eicke
    CARDIOVASCULAR RESEARCH, 2014, 103 (04) : 435 - 437
  • [49] Roles of LOX-1 in microvascular dysfunction
    Lubrano, Valter
    Balzan, Silvana
    MICROVASCULAR RESEARCH, 2016, 105 : 132 - 140
  • [50] Design of a novel LOX-1 receptor antagonist mimicking the natural substrate
    Falconi, Mattia
    Ciccone, Sarah
    D'Arrigo, Paola
    Viani, Fiorenza
    Sorge, Roberto
    Novelli, Giuseppe
    Patrizi, Patrizia
    Desideri, Alessandro
    Biocca, Silvia
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 438 (02) : 340 - 345